Insider trade

Biote (BTMD): Director bought ~$148K

Stephen Mark Cone, Director at Biote, bought ~$148K of Biote shares.

~$148K
Approx. value · 38K sh @ $3.88
161K
Holds after · shares reported
Traded
Mar 17, 2025
Filed
Mar 18, 2025

What stands out in this filing

  • The purchase added 31.0% to the shares this insider held before it; the filing reports 160,829 shares afterwards.
  • 38,104 shares at an average of $3.88 each, as reported on the form.
  • 4 other insiders at BTMD also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 13, 2025Insider10% owner purchased ~$2.41M of BTMD shares in the open market
  2. Mar 14, 2025Insider10% owner purchased ~$372K of BTMD shares in the open market
  3. Mar 17, 2025 · this disclosureInsiderDirector purchased ~$148K of BTMD shares in the open market

What came next

  1. Mar 17, 2025Insider · 4 peopleInsiders: 5 purchases (~$859K)
  2. Mar 31, 2025Insider10% owner purchased ~$352K of BTMD shares in the open market
  3. Apr 3, 2025Insider10% owner purchased ~$24K of BTMD shares in the open market
  4. Apr 4, 2025Insider10% owner purchased ~$77K of BTMD shares in the open market
  5. Apr 7, 2025Insider10% owner purchased ~$137K of BTMD shares in the open market
  6. Apr 8, 2025Insider10% owner purchased ~$112K of BTMD shares in the open market
  7. Apr 9, 2025Insider10% owner purchased ~$43K of BTMD shares in the open market
  8. Apr 16, 2025Insider10% owner purchased ~$3.3K of BTMD shares in the open market
  9. Apr 17, 2025Insider10% owner purchased ~$23K of BTMD shares in the open market
  10. Apr 21, 2025Insider10% owner purchased ~$29K of BTMD shares in the open market
  11. Apr 30, 2025Insider10% owner purchased ~$6.4K of BTMD shares in the open market
  12. May 6, 2025Insider10% owner purchased ~$1.42M of BTMD shares in the open market
  13. May 7, 2025Insider10% owner purchased ~$39K of BTMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biote

For Biote, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BTMD page.

How this filing works

Explore the data

Common questions

Which Biote (BTMD) insider traded, and how much?

Stephen Mark Cone, Director at Biote, bought ~$148K of Biote shares. 38K shares at $3.88, open market.

When did it happen, and when was it made public?

Traded: Mar 17, 2025. Filed: Mar 18, 2025. That is 1 day between the two dates.

What stands out in this filing?

The purchase added 31.0% to the shares this insider held before it; the filing reports 160,829 shares afterwards. 38,104 shares at an average of $3.88 each, as reported on the form. 4 other insiders at BTMD also bought in the open market within 30 days.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Biote recently?

For Biote, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BTMD page.

Does this mean BTMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Biote

Everything OQRO holds on this company is on its BTMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data